BiomX PHGE
NYSE PHGE
$0.14 0.00 (-1.57%)
At close: Aug 21, 2026 · 4:00 PM EDT

BiomX (PHGE) Short-term Investments (2018 - 2025)

BiomX (PHGE) posted Short-term Investments of $595000.0 for Q4 2025, down 39.59% sequentially from $985000.0 in Q3 2025, and down 37.89% YoY from $958000.0 in Q4 2024.

BiomX (PHGE) Short-term Investments (2018 - 2025) Analysis & Trends

BiomX has reported Short-term Investments for 8 years, with the latest figure at $595000.0 in Q4 2025.

  • Quarterly Short-term Investments fell 37.89% year-over-year to $595000.0 in Q4 2025, while the trailing twelve-month figure through Dec 2025 was $595000.0 (down 37.89% YoY) and the FY2025 annual result came in at $595000.0, down 37.89% from the prior year.
  • Short-term Investments slipped to $595000.0 in Q4 2025 per PHGE's latest filing, from $985000.0 in the prior quarter.
  • Over five years, Short-term Investments peaked at $8.0 million in Q2 2022 and troughed at $90000.0 in Q4 2022.
  • A 5-year average of $1.4 million and a median of $977500.0 in 2021 frame the typical range for Short-term Investments.
  • The sharpest annual moves came in 2022 and 2023: Short-term Investments slumped 90.96% in 2022, then jumped 963.33% in 2023.
  • Over 5 years, Short-term Investments stood at $996000.0 in 2021, then plunged by 90.96% to $90000.0 in 2022, then surged by 963.33% to $957000.0 in 2023, then rose by 0.1% to $958000.0 in 2024, then slumped by 37.89% to $595000.0 in 2025.
  • According to Business Quant data, Short-term Investments over the past three periods registered $595000.0, $985000.0, and $979000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Vertex Pharmaceuticals 139.13 Bn 131.28 Bn 2.84 Bn
2 Regeneron Pharmaceuticals 85.77 Bn 77.77 Bn 3.93 Bn
3 Argenx Se 64.64 Bn 59.46 Bn 1.37 Bn
4 Moderna 58.29 Bn 53.16 Bn 52.00 Mn
5 BeOne Medicines 41.92 Bn 36.82 Bn 1.53 Bn
6 Alnylam Pharmaceuticals 31.58 Bn 28.28 Bn 992.69 Mn
7 BioNTech SE 28.12 Bn 9.73 Bn 668.28 Mn
8 Insmed 27.39 Bn 26.22 Bn 358.27 Mn
9 Royalty Pharma 27.27 Bn 26.43 Bn -
10 BiomX 351,774.34 -816,225.66 -

Historic Data

Download Data
DateValue
Dec 31, 2025 595,000.00
Sep 30, 2025 985,000.00
Jun 30, 2025 979,000.00
Mar 31, 2025 953,000.00
Dec 31, 2024 958,000.00
Sep 30, 2024 1.11 Mn
Jun 30, 2024 1.10 Mn
Mar 15, 2024 154,000.00
Dec 31, 2023 957,000.00
Sep 30, 2023 943,000.00
Jun 30, 2023 951,000.00
Mar 31, 2023 956,000.00
Dec 31, 2022 90,000.00
Sep 30, 2022 3.50 Mn
Jun 30, 2022 8.00 Mn
Mar 31, 2022 990,000.00
Dec 31, 2021 996,000.00
Sep 30, 2021 985,000.00
Jun 30, 2021 982,000.00
Mar 31, 2021 976,000.00